SCHEMBL30926520

SCHEMBL30926520

O=C(Nc1cccc(S(=O)(=O)Nc2ccc(Cl)cc2)c1)c1ccnc(C(=O)O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.66
▸ KMT2A Q03164 9/20 0.66
▸ MAPT P10636 5/20 0.66
▸ HTT P42858 4/20 0.66
▸ LMNA P02545 3/20 0.66
▸ NPSR1 Q6W5P4 1/20 0.66
▸ SMN1; SMN2 Q16637 3/20 0.60
▸ MAPK1 P28482 2/20 0.60
▸ GAA P10253 1/20 0.57
▸ NR2F2 P24468 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ GRM4 Q14833 1/20 0.53
▸ IDH1 O75874 2/20 0.53
▸ NAMPT P43490 1/20 0.53
▸ TP53 P04637 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ PKM P14618 1/20 0.50
▸ ADORA3 P0DMS8 1/20 0.50
▸ SLC6A3 Q01959 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179949 1.00 MEN1 (0.66) MEN1KMT2AMAPTHTTLMNA
SCHEMBL27179830 0.82 MEN1 (0.69) MEN1KMT2AMAPTHTTLMNA
SCHEMBL7449594 0.82 MEN1 (0.84) MEN1KMT2AMAPTHTTLMNA
SCHEMBL27180650 0.82 MEN1 (0.68) MEN1KMT2AMAPTHTTLMNA
SCHEMBL30926752 0.82 MEN1 (0.68) MEN1KMT2AMAPTHTTLMNA
SCHEMBL27180909 0.80 MEN1 (1.00) MEN1KMT2AMAPTHTTLMNA
SCHEMBL30926981 0.80 MEN1 (1.00) MEN1KMT2AMAPTHTTLMNA
SCHEMBL27181470 0.80 MEN1 (0.73) MEN1KMT2AMAPTHTTLMNA
SCHEMBL30927046 0.79 MEN1 (0.66) MEN1KMT2AMAPTHTTLMNA
SCHEMBL30926962 0.79 MEN1 (0.66) MEN1KMT2AMAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885MAPT 4236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback